MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated diffuse large B-cell lymphoma (DLBCL), cementing the antibody-drug conjugate's ...

The wholesome video is now going viral The post St. Louis Blues sign 12-year-old Make-A-Wish kid for one day appeared first ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...

Lawmakers in a subcommittee Wednesday advanced Senate Study Bill 1051 2-1, which would protect pesticide manufacturers from litigation if they have "sufficient warning" product labels that comply with ...

The Twin Harbors community is rallying around a beloved Little League coach as he fights a cancer diagnosis. Steve Bove, who has long been associated as a coach and former president and supporter of ...

BREAKING NEWS: Blues sign 12-year old Carter Johnson to a 1-day contract. Carter, who grew up playing hockey in Nebraska, was ...

On Wednesday morning, St. Louis Blues Assistant General Manager Ryan Miller signed Carter Johnson to a one-day contract with ...

Our body fat may turn out to be a secret weapon in our everlasting fight against cancer. A new study released this week ...

Liposuction and plastic surgery aren't often mentioned in the same breath as cancer. But they are the inspiration for a new ...

Tea planter Vishal Mahindra was twice diagnosed with non-Hodgkin's lymphoma, a type of blood cancer that develops in the ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...